Cepheid Story Overview

CPHD -- USA Stock  

null 52.95  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for Cepheid. But even though we do not provide professional-grade financial sentiment analysis on Cepheid, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Cepheid. Check also Trending Equities.
Exercise or conversion by David Persing of 3 shares of Cepheid subject to Rule 16b-3
Filed transaction by Cepheid director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Cepheid insider trading alert for exercise of common stock by David Persing, Exec VPChief MedTech Officer, on October 7, 2017. This event was filed by Cepheid with SEC on 2011-11-01. SEC Form: Changes in beneficial ownership. David Persing is currently serves as executive vice president chief medical and technology officer, director of Cepheid

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Cepheid

few hours ago at www.macroaxis.com 
Cepheid exotic insider transaction detected
Macroaxis News
Filed transaction by Cepheid director. Unconventional Insider trading
few days ago at www.macroaxis.com 
Cepheid exotic insider transaction detected
Macroaxis News
Filed transaction by Cepheid director. Unconventional Insider trading
over a week ago at www.macroaxis.com 
Disposition of 25213 shares by Warren Kocmond of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Sale by Kerry Flom of 165 shares of Cepheidbusinessinsider News
Filed transaction by Cepheid officer. General open market or private sale of non-derivative or derivative security
over two weeks ago at www.macroaxis.com 
Disposition of 18472 shares by Fitzgerald Mike of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
over two weeks ago at http://theindustrytoday.com 
Acquisition by Thomas Gutshall of 12500 shares of Cepheid subject to Rule 16b-3
news
Filed transaction by Cepheid director. Grant, award or other acquisition pursuant to Rule 16b-3
over two weeks ago at http://moneybroker24.com 
Global Clinical Microbiology Market 2018 Analysis Biomerieux, Danaher, Becton Dickinson, Cepheid, Abbott ...
news
Money Broker 24 Full coverage
over three weeks ago at www.macroaxis.com 
Exercise or conversion by Thomas Gutshall of 12500 shares of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three weeks ago at http://theindustryherald.com 
Blood Culture Test Market Global Share 2018 and Analysis Abbott, Roche, Biomerieux and Beckman Coulter
news
The Industry Herald Full coverage
Acquisition by Kerry Flom of 28750 shares of Cepheid subject to Rule 16b-3businessinsider News
Filed transaction by Cepheid officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at www.macroaxis.com 
Exercise or conversion by Miller Andrew of 375 shares of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two months ago at http://thestockanalysis.com 
Antimicrobial Susceptibility Test Market to Expand at a CAGR of 4.6 percent from 2017 to 2025
news
Stock AnalysisFull coverage
over three months ago at www.macroaxis.com 
Exercise or conversion by Robert Easton of 5000 shares of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Shares Outstanding

Shares Outstanding Comparative Analysis

  Shares Outstanding 
      Cepheid Comparables 
Cepheid is currently under evaluation in shares outstanding category among related companies. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.

Peers

Cepheid Related Equities

Check also Trending Equities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
Search macroaxis.com